Mikhail Blagosklonny is a very renowned name for scientists and researchers of the Roswell Park Cancer Institute in New York, where he currently works and gives speeches.
Mikhail Blagosklonny is a specialist, an active scientific master and personality in the field of aging, having discovered one of the biggest achievements in the human history regarding combating the process of aging. He is one of the most respected figures in the oncology field, being one of the best scientists in the area, and he is steadily publishing some of his studies about cancer and aging on the internet, mainly on his peer-to-peer review journal, Oncotarget.
Having graduated from the First Pavlov State Medical University located in St. Petersburg, Russia, he was formed in that University in both his M.D. in internal medicine and his Ph.D. in experimental medicine and cardiology. Since that time, he was already one of the brightest students in the Oncology area, and the researching potential of the young scientist for the field was enormous. Visit ResearchGate to keep up to date with Mikhail’s latest work.
You can find work of Blagosklonny at your home, by searching one of the three core domains of the researcher: To learn more about “aging,” Google the journal with that same name. It is a very respected newsletter about the subject and the newest achievements and discoveries done on the anti-aging drugs phenomenon are weekly being posted on that website.
- Titled “Rejuvenating immunity: “anti-aging drug today,” Mikhail Blagosklonny released a crucial article for the world of scientific research, where he exposed a bit of the development of methods of using drugs to decrease the effects of aging and ultimately change forever everything that was common sense about the process of getting older.
While aging is a part of life, it is not a damage that is applied to the body over time, but rather a continuation of the process of natural growth during the person’s youth. Because of that, some exploits can be abused to try to mitigate the effects of this characteristic, which Mikhail Blagosklonny and his colleague scientists did.
Among the options that can be used to extend the life of humans, the team has found that using rapamycin and other rapalogs to increase the extension of the lifespan of a patient and prevent diseases is quite efficient and has proven to be a real therapy in the next few years to come. The use of rapalogs will mitigate the effect of conditions that get more common when the person ages, more notably, the effects of cancer, for example.
Called the TOR-centric model, this method of using drugs to target the TOR (Target of Rapamycin) will change what was taught about aging forever. Oncology will never be the same, and scientists are furthering their study of the Tor-centric method to this day, in 2017, and it will eventually become a real phenomenon where people can have a life expectancy of a hundred years or more.
Although it sounds utopic, Mikhail Blagosklonny assures it isn’t, because all of the most fantastic scientific discoveries done in the history of mankind seemed controversial or outright impossible at their time, only to be defended by numerous scientists, even after the death of the primary discoverer, which results in the next step for the life quality of mankind.